Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer

Lanxiang Huang(Wuhan University), Fubing Wang(Nantong University)
Molecular Cancer
February 11, 2022
10.1186/s12943-022-01515-x
Cited by 386

Related Papers

Macrophage membrane-coated iron oxide nanoparticles for enhanced photothermal tumor therapy
|Nanotechnology|2018|133
Glutathione-depleting nanoplatelets for enhanced sonodynamic cancer therapy
|Nanoscale|2021|58
Acoustic Droplet Printing Tumor Organoids for Modeling Bladder Tumor Immune Microenvironment within a Week
|Advanced Healthcare Materials|2021|57